About Cytek Biosciences, Inc.
https://cytekbio.comCytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
CEO
Wenbin Jiang
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 105
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:17.07M
Value:$94.91M
BLACKROCK, INC.
Shares:16.55M
Value:$92.01M
TOPLINE CAPITAL MANAGEMENT, LLC
Shares:6.94M
Value:$38.61M
Summary
Showing Top 3 of 160
About Cytek Biosciences, Inc.
https://cytekbio.comCytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $52.29M ▲ | $36.74M ▲ | $-5.48M ▲ | -10.48% ▲ | $-0.04 ▲ | $-4.21M ▼ |
| Q2-2025 | $45.6M ▲ | $34.49M ▼ | $-5.58M ▲ | -12.24% ▲ | $-0.04 ▲ | $-3.37M ▲ |
| Q1-2025 | $41.46M ▼ | $35.13M ▲ | $-11.4M ▼ | -27.5% ▼ | $-0.09 ▼ | $-8.09M ▼ |
| Q4-2024 | $57.48M ▲ | $30.67M ▼ | $9.64M ▲ | 16.78% ▲ | $0.07 ▲ | $-2.45M ▼ |
| Q3-2024 | $51.5M | $33.25M | $941K | 1.83% | $0.01 | $3.08M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $261.73M ▼ | $494.92M ▲ | $116.35M ▲ | $378.57M ▲ |
| Q2-2025 | $262.02M ▼ | $493.32M ▲ | $115.76M ▲ | $377.56M ▼ |
| Q1-2025 | $265.61M ▼ | $482.6M ▼ | $102.97M ▼ | $379.62M ▼ |
| Q4-2024 | $277.86M ▲ | $499.5M ▲ | $103.76M ▼ | $395.74M ▲ |
| Q3-2024 | $277.78M | $491.23M | $105.76M | $385.46M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-5.48M ▲ | $-3.9M ▼ | $18.92M ▲ | $1.94M ▲ | $17.81M ▲ | $-4.55M ▼ |
| Q2-2025 | $-5.58M ▲ | $108K ▲ | $-16.41M ▼ | $-2.6M ▲ | $-19.83M ▼ | $-1.47M ▼ |
| Q1-2025 | $-11.4M ▼ | $-125K ▼ | $9.45M ▲ | $-11.54M ▼ | $-3.45M ▲ | $-976K ▼ |
| Q4-2024 | $9.64M ▲ | $2M ▼ | $-63.43M ▼ | $-3.64M ▲ | $-63.56M ▼ | $1.09M ▼ |
| Q3-2024 | $940K | $13.22M | $-15.81M | $-12.08M | $-15.62M | $12.41M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Product | $80.00M ▲ | $30.00M ▼ | $30.00M ▲ | $40.00M ▲ |
 Service | $0 ▲ | $40.00M ▲ | $40.00M ▲ | $40.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q3-2025 | Q1-2025 | Q2-2025 |
|---|---|---|---|---|
 Asia Pacific | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
 EMEA | $30.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
 Other | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 UNITED STATES | $50.00M ▲ | $30.00M ▼ | $20.00M ▼ | $20.00M ▲ |
CEO
Wenbin Jiang
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 105
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 4 of 4
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:17.07M
Value:$94.91M
BLACKROCK, INC.
Shares:16.55M
Value:$92.01M
TOPLINE CAPITAL MANAGEMENT, LLC
Shares:6.94M
Value:$38.61M
Summary
Showing Top 3 of 160